Throughout the last three months, 7 analysts have evaluated Vir Biotechnology (NASDAQ:VIR), offering a diverse set of opinions from bullish to bearish. The table below provides a snapshot of their ...

$VIR insiders have traded $VIR stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.

Vir Biotechnology, listed on the Nasdaq Global Select Market under the ticker symbol (NASDAQ:VIR), operates within the biotechnology industry, focusing on the development of treatments for serious ...